In particular, the activation of PPARγ, which is expressed in high grade gliomas, has been shown to have several antineoplastic effects on human and rat glioma cell lines, inducing growth arrest and apoptosis in vitro and in vivo [11, 12] and inhibiting CD133+ cells expansion [13]. The gene discussed is PPARG; the disease is central nervous system cancer.